ICU Medical, Inc. (ICUI)
161.41
+2.03
(+1.27%)
USD |
NASDAQ |
Oct 05, 16:00
161.41
0.00 (0.00%)
After-Hours: 20:00
ICU Medical Enterprise Value : 4.974B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 4.974B |
| October 01, 2026 | 4.919B |
| September 30, 2026 | 5.003B |
| September 29, 2026 | 5.076B |
| September 28, 2026 | 5.091B |
| September 25, 2026 | 5.114B |
| September 24, 2026 | 5.141B |
| September 23, 2026 | 5.073B |
| September 22, 2026 | 5.014B |
| September 21, 2026 | 4.870B |
| September 18, 2026 | 4.806B |
| September 17, 2026 | 4.813B |
| September 16, 2026 | 4.880B |
| September 15, 2026 | 4.887B |
| September 14, 2026 | 4.930B |
| September 11, 2026 | 4.902B |
| September 10, 2026 | 4.921B |
| September 09, 2026 | 5.015B |
| September 08, 2026 | 5.012B |
| September 04, 2026 | 5.180B |
| September 03, 2026 | 5.147B |
| September 02, 2026 | 5.236B |
| September 01, 2026 | 5.260B |
| August 31, 2026 | 5.314B |
| August 28, 2026 | 5.368B |
| Date | Value |
|---|---|
| August 27, 2026 | 5.368B |
| August 26, 2026 | 5.480B |
| August 25, 2026 | 5.546B |
| August 24, 2026 | 5.554B |
| August 21, 2026 | 5.561B |
| August 20, 2026 | 5.553B |
| August 19, 2026 | 5.672B |
| August 18, 2026 | 5.584B |
| August 17, 2026 | 5.553B |
| August 14, 2026 | 5.565B |
| August 13, 2026 | 5.568B |
| August 12, 2026 | 5.474B |
| August 11, 2026 | 5.542B |
| August 10, 2026 | 5.551B |
| August 07, 2026 | 5.604B |
| August 06, 2026 | 5.149B |
| August 05, 2026 | 5.150B |
| August 04, 2026 | 5.289B |
| August 03, 2026 | 5.314B |
| July 31, 2026 | 5.203B |
| July 30, 2026 | 5.200B |
| July 29, 2026 | 5.153B |
| July 28, 2026 | 5.134B |
| July 27, 2026 | 5.026B |
| July 24, 2026 | 4.926B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Baxter International, Inc. | 18.82B |
| Abbott Laboratories | 196.37B |
| AngioDynamics, Inc. | 587.18M |
| Alphatec Holdings, Inc. | 2.040B |
| AtriCure, Inc. | 2.711B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 19.09M |
| Revenue (Quarterly) | 552.19M |
| Total Expenses (Quarterly) | 533.10M |
| EPS Diluted (Quarterly) | 0.7621 |
| Gross Profit Margin (Quarterly) | 36.74% |
| Profit Margin (Quarterly) | 3.46% |
| Earnings Yield | 0.73% |
| Operating Earnings Yield | 3.59% |
| Normalized Earnings Yield | 1.982 |